Washington Trust Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Washington Trust Advisors's LLY Position: Q1 2026 in Review
Washington Trust Advisors increased its Eli Lilly (LLY) stake by 1.6% in Q1 2026, buying an estimated $17.2K and bringing the position to 1,064 shares worth $979K. The position accounts for 0.08% of the portfolio, ranked #114.
Washington Trust Advisors first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.12M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Washington Trust Advisors held 1,064 shares of Eli Lilly worth $979K as of Q1 2026.
- Washington Trust Advisors bought 17 Eli Lilly shares in Q1 2026, an estimated $17.2K.
- Eli Lilly made up 0.08% of Washington Trust Advisors's portfolio in Q1 2026, its #114 holding.
- Washington Trust Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
- Washington Trust Advisors's Eli Lilly position peaked at $1.12M in Q4 2025.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Washington Trust Advisors's 13F filing for Q1 2026, filed 6 Apr 2026.